210 related articles for article (PubMed ID: 22904336)
21. Smallpox vaccine. A tame virus runs amok.
Kaiser J
Science; 2007 Jun; 316(5830):1418-9. PubMed ID: 17556562
[No Abstract] [Full Text] [Related]
22. Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells.
Zaitseva M; Shotwell E; Scott J; Cruz S; King LR; Manischewitz J; Diaz CG; Jordan RA; Grosenbach DW; Golding H
J Virol; 2013 May; 87(10):5564-76. PubMed ID: 23468500
[TBL] [Abstract][Full Text] [Related]
23. Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia.
Laiton-Donato K; Ávila-Robayo P; Páez-Martinez A; Benjumea-Nieto P; Usme-Ciro JA; Pinzón-Nariño N; Giraldo I; Torres-Castellanos D; Nakazawa Y; Patel N; Wilkins K; Li Y; Davidson W; Burgado J; Satheshkumar PS; Styczynski A; Mauldin MR; Gracia-Romero M; Petersen BW
Emerg Infect Dis; 2020 Mar; 26(3):601-605. PubMed ID: 32091366
[TBL] [Abstract][Full Text] [Related]
24. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.
Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S
J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052
[TBL] [Abstract][Full Text] [Related]
25. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW
Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
[TBL] [Abstract][Full Text] [Related]
26. Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.
Smee DF; Bailey KW; Wong MH; Tarbet EB
Antivir Chem Chemother; 2011 May; 21(5):201-8. PubMed ID: 21566266
[TBL] [Abstract][Full Text] [Related]
27. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.
Trost LC; Rose ML; Khouri J; Keilholz L; Long J; Godin SJ; Foster SA
Antiviral Res; 2015 May; 117():115-21. PubMed ID: 25746331
[TBL] [Abstract][Full Text] [Related]
29. Methisazone in progressive vaccinia.
Brainerd HD; Hanna L; Jawetz E
N Engl J Med; 1967 Mar; 276(11):620-2. PubMed ID: 6018450
[No Abstract] [Full Text] [Related]
30. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
32. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW
J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of cidofovir in a murine model of disseminated progressive vaccinia.
Neyts J; Leyssen P; Verbeken E; De Clercq E
Antimicrob Agents Chemother; 2004 Jun; 48(6):2267-73. PubMed ID: 15155231
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.
Bray M
Antiviral Res; 2003 Apr; 58(2):101-14. PubMed ID: 12742570
[TBL] [Abstract][Full Text] [Related]
35. Progressive vaccinia in a military smallpox vaccinee - United States, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):532-6. PubMed ID: 19478722
[TBL] [Abstract][Full Text] [Related]
36. Progressive vaccinia.
Bray M; Wright ME
Clin Infect Dis; 2003 Mar; 36(6):766-74. PubMed ID: 12627361
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC.
Jesus DM; Moussatché N; Damaso CR
Int J Antimicrob Agents; 2009 Jan; 33(1):75-9. PubMed ID: 18804965
[TBL] [Abstract][Full Text] [Related]
38. Ocular vaccinia following exposure to a smallpox vaccinee.
Hu G; Wang MJ; Miller MJ; Holland GN; Bruckner DA; Civen R; Bornstein LA; Mascola L; Lovett MA; Mondino BJ; Pegues DA
Am J Ophthalmol; 2004 Mar; 137(3):554-6. PubMed ID: 15013881
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?
Napolitano PG; Ryan MA; Grabenstein JD
Am J Obstet Gynecol; 2004 Dec; 191(6):1863-7. PubMed ID: 15592266
[TBL] [Abstract][Full Text] [Related]
40. Smallpox: a 21st century killer?
Ratzan SC
J Health Commun; 2003; 8(1):1-3. PubMed ID: 12635807
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
